Genentech, Inc.
86
Plan:
Genentech, Inc. Tax Reduction Investment Plan
47
68
89
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 3 point difference between this plan's BrightScope Rating (86) and the top rated plan (89) could equate to:
[How is this calculated?]
[How is this calculated?]
3 additional years of workThe delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Genentech, Inc. Tax Reduction Investment Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 86, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Account Balances, Company Generosity, Salary Deferral, and Total Plan Cost. Genentech, Inc. Tax Reduction Investment Plan currently has over 14,500 active participants and over $1.7B in plan assets.
Retirement Plan Details
| Address |
1 Dna Way
South San Francisco, CA 94080 |
| Industry | Manufacturing |
| Administrator | Robert Andreatta |
| Net Plan Assets | $1,660,000,000 |
| Total Participants | 15,000 |
| Avg Account Balance | $120,000 |
Compare Other Companies in Peer Group
| Amgen | 89.0 |
| AstraZeneca Pharmaceuticals LP | 85.9 |
| Schering-Plough | 83.9 |
| Hospira | 79.8 |
| Unilever United States | 77.8 |
| Ecolab | 72.0 |
Comments